TLGT News and Press, Teligent Inc. From 08/05/19

Teligent (NASDAQ: TLGT ): Q2 Non-GAAP EPS of -$0.04 in-line; GAAP EPS of -$0.08 beats by $0.03 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019. Second Quarter 2019 Highlights Net revenues of $18.3 million fo...

BUENA, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday August 5 th , 2019 to discuss the 2 nd quarter 2019 financial results and busin...

BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and MedTech Conference June 19, 2019. The Conference is taking place June 18 th - June 19 th , 20...

Teligent, Inc. (TLGT) Q1 2019 Results Conference Call May 06, 2019 04:30 PM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Lucas Baranowski - Craig-Hallum Capital Lucas Lee - Raymond James Presentation ...

Teligent (NASDAQ: TLGT ): Q1 Non-GAAP EPS of -$0.09 misses by $0.02 ; GAAP EPS of -$0.16. More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

BUENA, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Net revenues of $13.1 million for...

BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday May 6 th , 2019 to discuss the 1 st  quarter 2019 financial results and bus...

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Teligent, Inc. (“Teligent” or the “Company”) (NASDAQ: TLGT ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...

BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the response to the Complete Response Letter (“CRL”) it receive...